One Step at a Time: Improving Chronic Obstructive Pulmonary Disease Outcomes with Optimal Use of Medication Devices
This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc, and Novartis Pharmaceuticals Corporation.
Timothy Reilly, PharmD, BCPS, CGP, FASCP
Clinical Assistant ProfessorErnest Mario School of PharmacyRutgers, The State University of New JerseyPiscataway, New Jersey
Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose.
Faculty
Timothy Reilly, PharmD, BCPS, CGP, FASCP
Pharmacy Times Office of Continuing Professional Education Planning Staff
Judy V. Lum, MPA, and Elena Beyzarov, PharmD
Pharmacy Times Editorial Staff
Kirk McKay and David Allikas
PTOCPE uses an anonymous peer reviewer as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Objectives
Upon completion of the educational activity, the participant should be able to:
- Discuss the clinical presentation and diagnostic criteria for chronic obstructive pulmonary disease (COPD).
- Review the role of bronchodilators and inhaled corticosteroids in the management of COPD and understand their place in therapy.
- Review currently available medication devices (eg, metered dose inhalers, dry powder inhalers, nebulizers) for managing COPD and use of patient-specific factors in device selection.
- Address the pharmacist's role in training patients on use of different types of inhalers, and the importance of conducting scheduled technique checks with patients.
Target audience: Pharmacists
Type of activity: Knowledge
Release date: July 12, 2013
Expiration date: July 12, 2015
Estimated time to complete activity: 2 hours
Fee: Free
Click here to view this lesson.
